Vadodara, India

Nilav Patel

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Nilav Patel

Introduction

Nilav Patel is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly with his work on vortioxetine. His innovative approach has led to the development of novel forms of this important compound.

Latest Patents

Nilav Patel holds 1 patent for his invention titled "Polymorphic forms of vortioxetine and its pharmaceutically acceptable salts." This patent provides polymorphic forms of vortioxetine and its pharmaceutically acceptable salts. Specifically, it relates to the novel crystalline forms of vortioxetine or its pharmaceutically acceptable salts. Moreover, the invention also includes an amorphous form of vortioxetine hydrobromide and a stable amorphous co-precipitate of vortioxetine hydrobromide with pharmaceutically acceptable excipients.

Career Highlights

Throughout his career, Nilav Patel has demonstrated a strong commitment to advancing pharmaceutical science. His work has not only contributed to the understanding of vortioxetine but has also paved the way for further research in this area. His innovative spirit and dedication to his field are evident in his patent work.

Collaborations

Nilav Patel has collaborated with esteemed colleagues such as Venkat Raman Jayaraman and Sanjiv Tomer. These collaborations have enriched his research and contributed to the successful development of his patented inventions.

Conclusion

Nilav Patel's contributions to the field of pharmaceuticals, particularly through his patent on vortioxetine, highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…